{"disease":{"id":"borderline-dyslipidemia","name":"borderline dyslipidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07372729","title":"Smartwatch-based Intervention for Cardiovascular Health (SWITCH)","phase":"NA","overall_status":"RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}